TAVEXIA.BO · BSE

TAVEXIA LIFECARE LIMITED

₹1.18

-0.84% (-₹0.01)

Prev. close

₹1.19

Volume

7,18,979

As of

24 Sept 2026

Price history

₹1.18+₹0.13 (+12.38%) · 3M
26 Aug 202624 Sept 2026
₹1.2₹0.9926 Aug02 Sept09 Sept17 Sept24 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on TAVEXIA LIFECARE LIMITED in the last 90 days.

Fundamentals

About TAVEXIA LIFECARE LIMITED

Tavexia Lifecare Limited engages in manufacturing and trading of burners in India. The company is involved in manufacturing, supply, retail, and wholesale of Kapoor Dani, burner, aroma burner, ceramic Kapoor Dani, aroma oil burner and aroma oil burner cum night lamp, and night lamps, as well as home and office decoration lighting products, flowerpots with lighting, lighting flower vase, and aroma burner with timer. It sells its products through outlets and online selling platforms portals, such as India Mart, Amazon, Flipkart, Snapdeal, etc. The company was formerly known as Sattva Sukun Lifecare Limited and changed its name to Tavexia Lifecare Limited in August 2026. Tavexia Lifecare Limited was incorporated in 1980 and is based in Mumbai, India.

Details

Sector

Consumer Defensive

Industry

Household & Personal Products

CEO

Mr. Mit Tarunkumar Brahmbhatt

Headquarters

Mumbai

Employees

11

Key stats

Market cap

₹45.65 Cr

EPS (TTM)

₹-0.02

Beta (1Y · daily vs NIFTY 50)

0.22

Beta (5Y · monthly vs NIFTY 50)

0.30

Shares float

10.82 Cr

EPS · quarter ended Jun 2026

₹-0.00

Financial Performance

01 · Financials

0 Cr10 Cr20 Cr30 Cr40 Cr0%200%400%600%FY23FY24FY25FY26
RevenueNet incomeEBITDARevenue growth YoY

The first plotted growth figure is computed against Mar 2022 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY23 growth needs FY22 filings, which the data source doesn't provide.

02 · Earnings Per Share (EPS)

0000FY23FY24FY25FY26

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-500%0%500%1000%FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr50 Cr100 Cr150 Cr0.2×0.4×0.6×FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr50 Cr100 Cr150 CrFY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

-20 Cr-10 Cr0 Cr10 CrFY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY22FY23FY24FY25FY26
₹1.54 Cr₹2.21 Cr₹3.55 Cr₹5.26 Cr₹32.25 Cr
EBITDA₹11.00 L₹1.02 Cr₹1.93 Cr₹3.66 Cr₹75.68 L
₹1.90 L₹55.35 L₹1.19 Cr₹2.49 Cr₹21.17 L
Diluted EPS₹0.04₹0.05₹0.11₹0.01

Depreciation & amortisation, Pretax income, Tax provision, Interest expense, Diluted EPS have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY22FY23FY24FY25FY26
₹16.36 Cr₹23.28 Cr₹26.58 Cr₹111.35 Cr
₹23.72 L₹16.66 L₹51.83 L₹3.51 Cr
Stockholders' equity₹15.49 Cr₹22.20 Cr₹23.96 Cr₹43.23 Cr

Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY22FY23FY24FY25FY26
₹-1.47 Cr₹-2.77 Cr₹10.90 L₹-14.34 Cr
Investing cash flow₹-9.68 Cr₹-2.77 Cr₹-48.19 L₹-3.61 Cr
Financing cash flow₹11.16 Cr₹5.51 Cr₹37.10 L₹19.32 Cr
Capital expenditure₹-1.58 Cr₹-21,000₹-48.19 L₹-3.19 Cr
End cash position₹7.06 L₹4.01 L₹3.82 L₹1.41 Cr

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

12 · Peer Comparison

Consumer Defensive

Company
Hindustan Unilever Limited₹4.58 L Cr₹1,933.542.99.4030.9%0.03+5.3%-24.2%
ITC Limited₹3.39 L Cr₹26817.14.6728.5%0.03+4.8%-33.2%
Nestle India Limited₹2.67 L Cr₹1,35170.166.7080.0%0.29+19.6%+14.6%
Avenue Supermarts Limited₹2.50 L Cr₹3,787.581.410.2212.1%0.10+16.0%-18.5%
Varun Beverages Limited₹1.48 L Cr₹431.2543.57.5415.5%0.13+7.1%-4.7%
Britannia Industries Limited₹1.19 L Cr₹4,89545.623.2549.6%0.27+7.5%-18.0%
Marico Limited₹1.08 L Cr₹824.5557.325.6641.9%0.13+26.2%+16.5%
United Spirits Limited₹1.02 L Cr₹1,423.358.811.4320.5%0.05+7.8%+5.4%
TATA CONSUMER PRODUCTS LIMITED₹98,404.87 Cr₹986.361.24.527.1%0.13+15.2%-13.5%
Godrej Consumer Products Limited₹90,025.26 Cr₹87547.07.1114.7%0.35+8.5%-26.2%
Dabur India Limited₹68,723.09 Cr₹385.734.96.0216.6%0.11+5.2%-25.5%
TAVEXIA LIFECARE LIMITED₹45.65 Cr₹1.191.060.5%0.08+512.7%

Ranked by market cap within Consumer Defensive, same metrics as the Fundamentals screener. Click a column to sort.

Documents

TAVEXIA.BO

Tavexia Lifecare proposes acquisition of 60% stake in Meyonex Pharmaceuticals

Prop News Time · 5 days ago

TAVEXIA.BO

Tavexia Lifecare Advances Strategic Growth Roadmap with Proposed Acquisition of Meyonex Pharmaceuticals

5 Dariya News · 9 days ago